Accretion Pharmaceuticals IPO opened for subscription on May 14 and closes on May 16. The price band is set at ?96 to ?101 per share. The company aims to raise ?29.75 crore for capital expenditures and debt repayment.
Accretion Pharmaceuticals IPO opened for subscription on May 14 and closes on May 16. The price band is set at ?96 to ?101 per share. The company aims to raise ?29.75 crore for capital expenditures and debt repayment.